Key result
Anticoagulation therapy in internal medicine requires a delicate, personalized balance between preventing thrombotic events and mitigating bleeding complications.
Why the study?
Clinicians must navigate an intricate equilibrium between preventing thrombotic events and managing bleeding risks when employing anticoagulation strategies in internal medicine.
This review emphasizes the importance of personalized anticoagulation strategies to balance the prevention of thrombotic events against the risk of bleeding complications.
May inform anticoagulation choices in complex cases; leaves open the need for randomized trials to define personalization protocols.
The use of anticoagulation therapies in internal medicine has become a cornerstone in the management of various medical conditions, ranging from atrial fibrillation and venous thromboembolism to thrombophilia and hypercoagulable states.This review paper aims to provide a comprehensive analysis of the intricate equilibrium that clinicians must navigate when employing anticoagulation strategies.The paper will delve into the pivotal role of anticoagulants in preventing thrombotic events, while concurrently addressing the inherent risks associated with these therapies, including bleeding complications.By synthesizing the latest clinical evidence and guidelines, the review will explore the evolving landscape of anticoagulation, incorporating discussions on novel oral anticoagulants, reversal agents, and personalized medicine approaches.Furthermore, the paper will shed light on the challenges encountered in specific patient populations, such as the elderly and those with comorbidities, emphasizing the need for tailored anticoagulation strategies.The intricate interplay between anticoagulation and concurrent medications, as well as the impact on patient outcomes, will be scrutinized.Additionally, the review will highlight emerging trends and advancements in anticoagulation management, including the role of biomarkers and predictive tools, as well as the integration of patient preferences into treatment decisions.Through a thorough examination of the risks and rewards associated with anticoagulation in internal medicine, this paper aims to guide clinicians in achieving a delicate balance that optimizes patient outcomes while minimizing potential adverse effects.
No takes yet. Share an insight, caveat, or question.
Likhita et al. (2023) conducted a review in Thrombotic disorders (e.g., atrial fibrillation, venous thromboembolism). Anticoagulation therapy was evaluated. Anticoagulation therapy in internal medicine requires a delicate, personalized balance between preventing thrombotic events and mitigating bleeding complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: